AptarGroup, Inc.

United Statesaptar.com

Owner Investor / Financier Operator Developer

project tracked
1
plants
3
news articles
30

AptarGroup, Inc. (Aptar) is a global designer and manufacturer of dispensing, dosing, sealing, and drug delivery solutions used across the pharmaceutical, beauty and personal care, home care, and food and beverage markets. Its portfolio includes pumps, aerosol valves, closures, droppers, spray and nasal systems, inhalation and ophthalmic devices, and active packaging that helps manage moisture and oxygen.

Read more

The company integrates polymer and elastomer materials science with precision molding, automation, and device engineering, and provides regulatory and analytical support for healthcare applications. Aptar’s businesses include Aptar Pharma, Aptar Beauty, Aptar Closures, Aptar Digital Health, and Aptar CSP Technologies. Headquartered in Crystal Lake, Illinois, USA, Aptar operates manufacturing and R&D sites worldwide, supplying components and systems that enable safe, reliable product delivery for consumer and healthcare brands.

Also known as AptarGroup, Aptar CSP Technologies, Aptar Digital Health, Aptar Closures, and Aptar Beauty + Home.

The project Aptar is involved in

chemXplore tracks 1 project involving Aptar.

Aptar Pharma Taloja Inhalation Technologies Expansion
Phase
Operational / Completed
Where
India

Aptar in chemical industry news

26 October 2026
Aptar Pharma acquires PULMOTREE to add Kolibri non‑propellant liquid inhaler

Adds Kolibri NPLI platform to support complex inhaled therapies including biologics, and integrates formulation, device, regulatory and digital services for end‑to‑end development.

14 October 2026
Aptar Pharma gains CE marking for LuerVax and Spray Divider

CE marking for a LuerLock‑compatible intranasal device and optional Spray Divider that delivers two sequential sprays (200 µL, 500 µL), supporting vaccine development from early clinical to commercial.

8 October 2026
Aptar expands pharma manufacturing in Mumbai

Adds local production of pMDI valves, breath‑actuated inhalation devices and multi dose nasal spray systems; site grows to 11,300 m² to improve regional supply resilience.

29 September 2026
Aptar Beauty and BVLGARI win Formes de Luxe Award 2026

10 ml refillable travel spray using Nomad Refill tech wins Formes de Luxe Award; custom anodized-aluminum casing with marble cap and patented connector for fast, clean refills.

14 September 2026
Aptar Pharma and Massachusetts General Hospital build predictive nose-to-brain delivery platform

Partners will create an integrated translational platform to quantify mechanisms, pathways and kinetics of nose-to-brain drug transport using in vitro, in vivo and computational tools.

11 September 2026
Aptar Pharma expands APF preservative-free pump production in Argentina

APF multidose preservative‑free pump line commissioned to serve Latin American markets, cutting lead times and improving local supply agility.

12 August 2026
Noble (Aptar Pharma) secures US patent for AI sound detection in drug-delivery and diagnostic devices

AI analyzes device-generated sounds to verify correct operation and provide objective feedback for training, usability studies and adherence in home self-administration.

10 June 2026
Aptar N‑Sorb patent allowed by USPTO for packaging-based nitrosamine mitigation

USPTO allowed a patent for N‑Sorb, a packaging material that reduces nitrosamines across multiple APIs and may support FDA Orange Book strategies.

Where its projects are

active all projects

  • India 0 active projects, 1 in all